Roubaud, G <br/><br/>
Clinical activity of sorafenib in patients with advanced gastrointestinal stromal tumor bearing PDGFRA exon 18 mutation: a case series.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Mar 2012 
 - 804-805 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdr631  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Benzenesulfonates--therapeutic use<br/>Exons--genetics<br/>Gastrointestinal Neoplasms--drug therapy<br/>Gastrointestinal Stromal Tumors--drug therapy<br/>Humans<br/>Mutation<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Pyridines--therapeutic use<br/>Receptor, Platelet-Derived Growth Factor alpha--genetics<br/>Sorafenib